All the published genetic association studies related to cytokines listed according to the polymorphisms examined.
1. Introduction
A short cold ischemic time, an optimal HLA match and other pre-transplant factors are in a key role in the success of kidney transplantation. Over the past decades, the acute rejection rate of kidney transplants has fallen dramatically and the 1-year graft survival rate has increased to 90% in transplantations with deceased donors and 95% with living related donors. This increase in graft survival is largely due to advances in immunosuppressant medication (Yates & Nicholson, 2006). But, due to undesired side effects usually associated with immunosuppressive regimens, reduced immunosuppression is warranted whenever possible.
Acute rejection has been the most common end point of genetic association studies. This is natural as acute rejection predicts decreased long-term allograft survival. Despite progress in immunosuppression, the long-term graft survival has not increased in patients suffering acute rejection episodes (Meier-Kriesche et al., 2004). In many genetic studies, chronic allograft nephropathy and subsequent graft loss have been the endpoints with which genetic variation has been compared.
1.1. Genetic polymorphisms affect on outcome of kidney transplantation
Although
1.1.1. Immune genes are interesting candidates
Immune genes, i.e. the genes encoding for molecules regulating or affecting immune responses, are involved in the etiopathology of autoimmune diseases and probably also in the outcome of organ transplantation. Polymorphisms in immune genes may induce functional or quantitative differences in immune responsiveness between patients, resulting in for example high and low cytokine producers. Single nucleotide polymorphisms (SNPs) can have an effect on gene expression, not only the SNPs located in exons, possibly changing amino acids, or in promoter regions, possibly changing the crucial regulatory sequences, but also polymorphisms in introns have been shown to be of importance in genetic susceptibility studies. Thus, although functional variants are the most relevant to study, all polymorphisms are potentially interesting. Immune genes encode, for example, cytokines, chemokines, growth factors and T cell co-activation molecules.
1.1.2. Cytokines are major regulators of the immune response
Most genetic association studies in kidney transplantation have focussed on the genes encoding cytokines. Variations in the cytokine genes may lead to differences in the levels of their production or signalling, which in turn may modulate the strength of the immune response. Thus, they are potential candidate genes related to organ transplantation as they may predict the overall immunological responsiveness of the patient toward the graft.
Cytokines can be classified on the basis of their function to the pro-inflammatory cytokines, such as tumor necrosis factor (TNF), interleukin (IL)1β, interferon (IFN) γ, IL6, IL12, IL17 and IL18, and to the anti-inflammatory cytokines, including IL4, IL10, IL13, IFNα and transforming growth factor (TGF) β. However, it is of note that the effect of any single cytokine may depend on the exact environment it is acting in. The balance between pro- and anti-inflammatory cytokines partially determines the level or strength of the immune response (Dinarello, 1997). Below, we present a few examples from the wide variety of cytokines.
1.1.2.1. Tumor necrosis factor
Perhaps the most actively studied cytokine in genetic studies is the tumor necrosis factor (TNF), which has multiple roles in innate immunity, apoptosis and metabolism. TNF stimulates neutrophil and macrophage function and is a key mediator of inflammation. Production of TNF leads to massive inflammatory reactions in response to several immunological challenges (Hehlgans & Pfeffer, 2005). TNF and its receptors could be useful biomarkers for organ rejection, as TNF is not detectable in healthy individuals, but elevated serum levels are found in kidney transplant recipients (Maury & Teppo, 1987).
The
1.1.2.2. Transforming growth factor β 1
Mammals have three isoforms of transforming growth factor β (TGFβ-1, TGFβ-2 and TGFβ-3) (Derynck et al., 1985). TGFβ-1 is the most abundant and most studied of the isoforms. It is a strong anti-inflammatory cytokine that regulates proliferation, apoptosis and differentiation of many cell types. TGFβ-1 affects T cell survival and Th differentiation for example regulating the development of effector cells and induction of Treg cells (Rubtsov & Rudensky, 2007). TGFβ-1 activates a profibrotic process and its increased expression has been associated with chronic rejection (Campistol et al., 2001).
The
1.1.2.3. Interleukin 10
Interleukin 10 (IL10) promotes the Th2-type immune response and B-cell mediated functions leading to antibody production. Besides, it inhibits the Th1-type immune response by suppressing the expression of proinflammatory cytokines, hence being anti-inflammatory. IL10 also inhibits antigen presenting cells by downregulating the expression of HLA class II molecules (Ding et al., 1993).
The
1.1.2.4. Interferon γ
IFNγ is a proinflammatory cytokine produced by activated T cells. IFNγ has several roles in the immune response: it activates macrophages, mediates the lytic effect, potentiates the actions of other interferons and it also inhibits intracellular microorganisms other than viruses (Dianzani & Baron, 1996). IFNγ acts both as an anti-rejection and pro-rejection cytokine, e.g. by inducing microvascularisation in the grafted organ and up-regulating the expression of HLA molecules. The predominant effect mainly depends on the secretion time after transplantation, being protective early on and then later becoming antagonistic (Hidalgo & Halloran, 2002).
The
1.1.3. Co-stimulatory receptors mediate T cell activation
Besides cytokine genes, another interesting gene group is those coding for T cell co-stimulatory receptors. Co-stimulatory signals are essential for the activation of naïve T cells and productive immune response. For activation, naïve T cells must receive an antigen-specific signal through the T cell receptor and additionally a signal by co-stimulatory receptors. Without the co-stimulatory signal the T cell turns anergic. In addition, the co-stimulatory signal can be negative, that is, inhibitory after the initial activation. The fine balance between the positive and negative signals determines the outcome of an immune response.
1.1.3.1. CD28 is an essential co-stimulator
The CD28 pathway is crucial for T cell activation; signalling through CD28 increases cytokine production in T cells, by enhancing transcriptional activity and stabilizing messenger RNA (Thompson et al., 1989). CD28 ligation also reduces the number of engaged TCRs that are needed for proliferation or effective cytokine production, thereby lowering the threshold for T cell activation (Viola & Lanzavecchia, 1996). CD28 is expressed constitutively on T cells and it binds to ligands B7-1 (CD80) and B7-2 (CD86) found primarily on antigen presenting cells. These ligands have distinct but overlapping functions; B7-2 may mediate initial T cell activation, while B7-1 may be more important for maintaining the immune response (Vincenti & Luggen, 2007). Antigen specific signal without CD28 mediated signal turns T cells anergic.
Located on chromosome 2q33, the
1.1.3.2. CTLA4 has an inhibitory function
Cytotoxic T lymphocyte associated antigen 4 (CTLA4) mediates a critical inhibitory signal for T cell activation. CTLA4 binds with higher affinity, to the same B7 ligands as CD28. It is induced on T cells after their activation, and functions in the downregulation of T cell activation; CTLA4 ligation raises the activation threshold for T cells. CTLA4 decreases interleukin 2 (IL2) and IL2 receptor expression and arrests T cells at the G1 phase of the cell cycle (Vincenti & Luggen, 2007). The CTLA4 pathway may have an important role in peripheral T cell tolerance (Yamada et al., 2002). Principal evidence for an inhibitory function of CTLA4 was obtained from CTLA4 knockout mice. These CTLA4 deficient (CTLA4-/-) mice develop a fatal lymphoproliferative disorder with multiorgan autoimmune disease (Tivol et al., 1995; Waterhouse et al., 1995).
1.1.3.3. ICOS induces cytokine expression
Inducible co-stimulator (ICOS) plays a critical, independent role in T cell activation, in a manner that is synergistic with CD28 signalling. ICOS augments effector T cell cytokine responses; in particular, it appears to superinduce production of the anti-inflammatory cytokine IL10 (Hutloff et al., 1999). ICOS expression is enhanced on activated T cells by CD28 co-stimulation (Beier et al., 2000). ICOS binds B7 related protein 1, (B7RP-1) which is expressed constitutively by B cells and macrophages (Yoshinaga et al., 1999) but can also be induced on non-lymphoid cells by inflammatory stimuli (Swallow et al., 1999). ICOS knockout mice have reduced CD4+ T cell responses (Dong et al., 2001) as well as defects in immunoglobulin (Ig) class switching (McAdam et al., 2001).
1.1.3.4. Therapeutic potential of co-stimulatory receptors
Blockade of the CD28 co-stimulatory pathway provides a promising therapeutic strategy for transplantation. CTLA4-Ig is a fusion protein which consists of the extracellular binding domain of CTLA4 linked to a modified Fc domain of human antibody IgG. The Fc domain mediates complement activation and interacts with Fc cell surface receptors. The CTLA4 fragment defines the specific targets of the fusion antibody, which are the B7 ligands. It was developed to selectively interrupt full T cell activation by blocking the interaction of CD28 and B7 ligands (Vincenti & Luggen, 2007). The use of CTLA4-Ig is effective in inducing long-term allograft survival in solid organ transplantation in mouse, rat and primate models (Snanoudj et al., 2006). The first clinical trial with CTLA4-Ig in human renal transplantation showed promise although immunosuppressive drug cyclosporine was still more effective in preventing acute rejection (Vincenti, 2005).
The impact of the ICOS co-stimulation pathway on emerging rejection episodes has been demonstrated by anti-ICOS therapy (Özkaynak et al., 2001). Anti-ICOS antibody treatment has also been studied together with anti-CD40L and CTLA4-Ig in animal models of transplantation; the animals displayed fewer signs of chronic rejection (Snanoudj et al., 2006).
2. Accumulated literature of immune gene studies
In this review, we aim to examine all the published association studies of potential candidate genes of cytokines and co-stimulatory receptors. We did a systematic search for literature in the PubMed database (National Library of Medicine, Bethesda, MD, US; www.ncbi.nlm.nih.gov/pubmed). We used search terms renal transplant, renal transplantation, kidney transplant or kidney transplantation and gene*, polymorphism or SNP. Literature addressing genetic association studies related to cytokines and co-stimulatory receptors was selected. Articles not reported in English were excluded; otherwise no limitations were set on the publishing manner.
3. Results
We found 85 original articles which are listed in Tables 1 and 2. Most genetic association studies in kidney transplantation focus on cytokine genes. Despite the number of reported positive associations with cytokine genes, the results are confusing because different studies report differing variants as demonstrating the strongest association. All the genetic associations are listed in the Tables 1 and 2 as they have been published although most of them are just nominally significant, and only in a few studies, the correction for multiple testing is performed appropriately.
3.1. Cytokine genes associate with poor outcome of kidney transplantation
The
The variants of the
A total of 237 kidney transplantation patients were included in a multicentre study by Grinyo et al (2008), in which associations were found between the
In a recent study by Israni et al (2010), altogether 2,724 SNPs were genotyped in a total of 990 kidney recipients. They found several SNPs to be associated with acute rejection and its severity, among them a polymorphism in the gene of the cytokine IL15 receptor. An interesting finding to arise from this multicentre study was the significant difference (P<0.0001) in rates of acute rejection (0-30%) between different transplantation centres. The data was stratified by centres, thus associations were not masked by the centre to centre variation. This stratification could also be recommended for other multicentre studies. The authors speculated that the variation between transplantation centres can explain why associations are so difficult to repeat in other patient cohorts from different transplantation centres (Israni et al., 2010).
3.2. Co-stimulator receptor genes may predispose to the poor outcome of transplantation
Two of the genetic variants of
Variants of the
The distance between the genetic markers used and the actual risk factor may be long due to the strong LD in the region (Holopainen & Partanen, 2001). A thorough examination of polymorphisms within the 2q33 region is necessary for the reliable identification of the primary variant. The association analyses of the published co-stimulator gene studies are solely limited to a few markers in the
|
dbSNP rs number |
Citation Association |
Citation No association |
TNF -308G"/A | rs1800629 | Sankaran et al., 1999; Pelletier et al., 2000; Poli et al., 2000; Hahn et al., 2001; Reviron et al., 2001; Wramner et al., 2004; Park et al., 2004; donor: Nikolova et al., 2008 | Hutchings et al., 2002; Marshall et al., 2000; Cartwright et al., 2001; George et al., 2001; Muller-Steinhardt et al., 2002; Weimer et al., 2003; McDaniel et al., 2003; Uboldi de Capei et al., 2004; Ligeiro et al., 2004; Dmitrienko et al., 2005; Gendzekhadze et al., 2006; Azarpira et al., 2006; Brabcova et al., 2007; Breulmann et al., 2007; Satoh et al., 2007; Rodrigo et al., 2007; Alakulppi et al., 2008; Azarpira et al., 2009; Kao et al., 2010; Jacobson et al., 2010; Khan et al., 2010; Omrani et al., 2010; Israni et al., 2010; Kocierz et al., 2011; donor: Sankaran et al., 1999; Poole et al., 2001; Marshall et al., 2001; Hoffmann et al., 2004;Alakulppi et al., 2004; Ligeiro et al., 2004; Israni et al., 2008; Manchanda & Mittal; 2008; Mendoza-Carrera et al., 2008; ; Azarpira et al., 2009; Lobashevsky et al., 2009 |
TNF -238G"/A | rs361525 | Rodrigo et al., 2007; Satoh et al., 2007; Lobashevsky et al., 2009; Kao et al., 2010; Khan et al., 2010 | |
TNF +123G"/A | rs1800610 | Israni et al., 2010; Jacobson et al., 2010 | |
TNF +851G"/A | rs3093662 | Israni et al., 2010; Jacobson et al., 2010; donor: ADDIN RW.CITE{{11388 Israni,A.K. 2008}}Israni et al., 2008 | |
TNF +3512G"/A | rs1800628 | donor: Israni et al., 2008 | |
TGFB1 +869T"/C and +915C"/G | rs1800470, (rs1982073), rs1800471 | McDaniel et al., 2003;Alakulppi et al., 2004; Park et al., 2004; Dmitrienko et al., 2005; Tinckam et al., 2005; Lacha et al., 2005; Hueso et al., 2006; Amirzargar et al., 2007; Manchanda et al., 2008; Nikolova et al., 2008; Kocierz et al., 2011; donor: Park et al., 2004; Ligeiro et al., 2004; Hoffmann et al., 2004; Lacha et al., 2005; Canossi et al., 2007; Nikolova et al., 2008 |
Pelletier et al., 2000; Marshall et al., 2000; Hutchings et al., 2002; Muller-Steinhardt et al., 2002; Ligeiro et al., 2004; Uboldi de Capei et al., 2004;Mytilineos et al., 2004; Gendzekhadze et al., 2006; Brabcova et al., 2007; Coppo et al., 2007; Satoh et al., 2007; Rodrigo et al., 2007; Manchanda & Mittal, 2008; Grinyo et al., 2008; Mendoza-Carrera et al., 2008; Cho et al., 2008; Khan et al., 2010; Jacobson et al., 2010; Israni et al., 2010; Omrani et al., 2010; Lobashevsky et al., 2009; La Manna et al., 2010; Kozak et al., 2011; donor: Poole et al., 2001; Marshall et al., 2001;Alakulppi et al., 2004; Israni et al., 2008; Manchanda & Mittal, 2008; Mendoza-Carrera et al., 2008 |
TGFB1 exon 5 (713-8delC) | rs8179182 | Manchanda et al., 2008 | Manchanda & Mittal, 2008; donor: Manchanda & Mittal, 2008 |
TGFB1 -509C"/T | rs1800469 | Satoh et al., 2007; Cho et al., 2008;Grenda et al., 2009; Kozak et al., 2011 | |
TGFB1 +11929C"/T | rs1800472 | donor:Israni et al., 2008 | |
TGFB1 -800G"/A | rs1800468 | Kozak et al., 2011 | |
IL10 -1082G"/A | rs1800896 | Sankaran et al., 1999; George et al., 2001; Hutchings et al., 2002; McDaniel et al., 2003; Uboldi de Capei et al., 2004; Alakulppi et al., 2004; Tinckam et al., 2005; Lacha et al., 2005; Canossi et al., 2007; Coppo et al., 2007; Nikolova et al., 2008; Khan et al., 2010; Amirzargar et al., 2007; La Manna et al., 2010; donor: Nikolova et al., 2008 |
Pelletier et al., 2000; Cartwright et al., 2000; Marshall et al., 2000; Hahn et al., 2001; Poole et al., 2001; Cartwright et al., 2001; Asderakis et al., 2001; Muller-Steinhardt et al., 2002; Weimer et al., 2003; Plothow et al., 2003; Mytilineos et al., 2004;Ligeiro et al., 2004; Dmitrienko et al., 2005; Loucaidou et al., 2005; Azarpira et al., 2006; Rodrigo et al., 2007; Breulmann et al., 2007; Grinyo et al., 2008; Gendzekhadze et al., 2006; Manchanda & Mittal, 2008; Mendoza-Carrera et al., 2008; Alakulppi et al., 2008; Grenda et al., 2009; Lobashevsky et al., 2009; Azarpira et al., 2009; Jacobson et al., 2010; Omrani et al., 2010; Kocierz et al., 2011; Israni et al., 2010; donor: Sankaran et al., 1999; Poole et al., 2001; Marshall et al., 2001;Alakulppi et al., 2004; Hoffmann et al., 2004; Ligeiro et al., 2004; Lacha et al., 2005; Loucaidou et al., 2005; Manchanda & Mittal, 2008; Mendoza-Carrera et al., 2008; Azarpira et al., 2009 |
IL10 -819C"/T and -592C"/A | rs1800871 rs1800872 | McDaniel et al., 2003; Alakulppi et al., 2004; Ligeiro et al., 2004; Tinckam et al., 2005; Lacha et al., 2005; Coppo et al., 2007; Amirzargar et al., 2007; Nikolova et al., 2008; Grinyó 2008; Khan et al., 2010; La Manna et al., 2010; donor:Alakulppi et al., 2004; Nikolova et al., 2008 |
Cartwright et al., 2000; Marshall et al., 2000; Cartwright et al., 2001; Muller-Steinhardt et al., 2002; Weimer et al., 2003; Plothow et al., 2003;Mytilineos et al., 2004; Uboldi de Capei et al., 2004; Loucaidou et al., 2005; Gendzekhadze et al., 2006; Rodrigo et al., 2007; Satoh et al., 2007; Manchanda & Mittal, 2008; Alakulppi et al., 2008; Mendoza-Carrera et al., 2008; Lobashevsky et al., 2009; Jacobson et al., 2010; Israni et al., 2010; Kocierz et al., 2011; donor: Marshall et al., 2001; Ligeiro et al., 2004; Hoffmann et al., 2004; Loucaidou et al., 2005;Lacha et al., 2005; Manchanda & Mittal, 2008; Mendoza-Carrera et al., 2008 |
IL10 -851C"/T | rs1800894 | Grinyo et al., 2008 | |
IL10 +4259A"/G | rs3024498 | donor: Israni et al., 2008 | |
IL10 +434C"/T | rs2222202 | donor: Israni et al., 2008 | |
IL10 IVS3-112A"/G | rs3024494 | donor: Israni et al., 2008 | |
IL10 IVS3-474C"/G | rs1878672 | donor: Israni et al., 2008 | |
IL10 gIVS3+284G"/T | rs3024493 | donor:Israni et al., 2008 | |
IL10 IVS3+19T"/C | rs1554286 | donor: Israni et al., 2008 | |
IL10 IVS1-192A"/C | rs3021094 | donor: Israni et al., 2008 | |
IL6 -174G"/C | rs1800795 | Hahn et al., 2001; Reviron et al., 2001; Muller-Steinhardt et al., 2002; Lacha et al., 2005; Nikolova et al., 2008; Pawlik et al., 2008; Kocierz et al., 2011; donor: Marshall et al., 2001; Ligeiro et al., 2004; Canossi et al., 2007; Nikolova et al., 2008 |
Cartwright et al., 2000; Cartwright et al., 2001; Marshall et al., 2001; Hutchings et al., 2002; McDaniel et al., 2003; Ligeiro et al., 2004; Uboldi de Capei et al., 2004;Alakulppi et al., 2004; Hoffmann et al., 2004; Loucaidou et al., 2005; Tinckam et al., 2005; Gendzekhadze et al., 2006; ; Coppo et al., 2007; Breulmann et al., 2007; Satoh et al., 2007; Rodrigo et al., 2007; Alakulppi et al., 2008; Manchanda et al., 2008; Manchanda & Mittal; 2008; Grenda et al., 2009; Martin et al., 2009; Kruger et al., 2009; Lobashevsky et al., 2009; Khan et al., 2010; Jacobson et al., 2010; Sanchez-Velasco et al., 2010; La Manna et al., 2010; Israni et al., 2010; donor: Alakulppi et al., 2004; Loucaidou et al., 2005; Lacha et al., 2005; Manchanda & Mittal, 2008; Martin et al., 2009; Krajewska et al., 2009 |
IL6 +565"/A | rs1800797 | Rodrigo et al., 2007; Lobashevsky et al., 2009 | |
IL6 +1888G"/T | rs1554606 | Kruger et al., 2009 | |
IL6 Pro32Ser | rs2069830 | Kruger et al., 2009 | |
IL6 Asp162Val | rs2069860 | Kruger et al., 2009 | |
IFNG +874T"/A | rs2430561 | McDaniel et al., 2003; Tinckam et al., 2005; Mendoza-Carrera et al., 2008; Nikolova et al., 2008; Lobashevsky et al., 2009; Zibar et al., 2011; donor: Hoffmann et al., 2004; Canossi et al., 2007; Nikolova et al., 2008 | Hahn et al., 2001; Hutchings et al., 2002; Muller-Steinhardt et al., 2002; Ligeiro et al., 2004; Alakulppi et al., 2004; Uboldi de Capei et al., 2004; Azarpira et al., 2006; Gendzekhadze et al., 2006; Brabcova et al., 2007; Coppo et al., 2007; Rodrigo et al., 2007; Satoh et al., 2007; Azarpira et al., 2009; Singh et al., 2009; Khan et al., 2010; Omrani et al., 2010; Crispim et al., 2010; La Manna et al., 2010; Kocierz et al., 2011; donor:Alakulppi et al., 2004; Ligeiro et al., 2004; Mendoza-Carrera et al., 2008; Azarpira et al., 2009 |
IFNG (CA)n | rs2234688 | Mendoza-Carrera et al., 2008 | donor: Mendoza-Carrera et al., 2008 |
IL1A -889T"/C | rs1800587 | Jin & Ruiz, 2008; donor: Jin & Ruiz, 2008 |
Rodrigo et al., 2007; Lobashevsky et al., 2009; Khan et al., 2010 |
IL1B -31C"/T | rs1143627 | Grenda et al., 2009 | |
IL1B -511C"/T | rs16944 | Rodrigo et al., 2007, Jin & Ruiz, 2008; donor: Jin & Ruiz, 2008 | Manchanda & Mittal, 2008; Khan et al., 2010; donor:Manchanda & Mittal, 2008 |
IL1B +3962C"/T | rs1143634 | Manchanda & Mittal, 2008; Jin & Ruiz, 2008; donor:Jin & Ruiz, 2008 |
Rodrigo et al., 2007;Manchanda & Mittal, 2008; Lobashevsky et al., 2009; Khan et al., 2010; donor:Manchanda & Mittal, 2008; Krajewska et al., 2009; Khan et al., 2010 |
IL1R +1970C"/T | rs2234650 | Rodrigo et al., 2007; Lobashevsky et al., 2009 | |
IL1RA +11100 T"/C | rs315952 | Rodrigo et al., 2007; Lobashevsky et al., 2009; Khan et al., 2010, | |
IL1RN VNTR | rs2234663 | Jin & Ruiz, 2008; donor: Jin & Ruiz, 2008 | Manchanda & Mittal, 2008; Grenda et al., 2009; donor: Manchanda & Mittal, 2008 |
IL2 -330T"/G | rs2069762 | Satoh et al., 2007 | Rodrigo et al., 2007; Grinyo et al., 2008; Manchanda et al., 2008; Manchanda & Mittal, 2008; Pawlik et al., 2008; Lobashevsky et al., 2009; donor: Manchanda & Mittal, 2008 |
IL2 +166G"/T | rs2069763 | Rodrigo et al., 2007; Grinyo et al., 2008; Lobashevsky et al., 2009 | |
IL3 +132C"/T | rs40401 | Lee et al., 2010 | |
IL3 -1107G"/A | rs181781 | Lee et al., 2010 | |
IL3 -1484G"/A | rs2073506 | Lee et al., 2010 | |
IL4 VNTR intron 3 | rs8179190 | Manchanda et al., 2008 | Manchanda & Mittal, 2008; donor: Manchanda & Mittal, 2008 |
IL4 -1098T"/G | rs2243248 | Rodrigo et al., 2007; Lobashevsky et al., 2009 | |
IL4 -590T"/C | rs2243250 | Rodrigo et al., 2007, Satoh et al., 2007; Pawlik et al., 2008; Lobashevsky et al., 2009 | |
IL4 -33T"/C | rs2070874 | Rodrigo et al., 2007; Lobashevsky et al., 2009 | |
IL4R +1902G"/A | rs1801275 | Lobashevsky et al., 2009 | Rodrigo et al., 2007 |
IL8 -251A"/T | rs4073 | Singh et al., 2009 | La Manna et al., 2010; Ro et al., 2010; donor:Ro et al., 2010 |
IL12 -1188C"/A | rs3212227 | Rodrigo et al., 2007; Hoffmann et al., 2008; Lobashevsky et al., 2009 | |
IL12A +8685G"/A | rs568408 | Jacobson et al., 2010 | Israni et al., 2010 |
IL12B -1188C"/A | rs3212227 | Kolesar et al., 2007; Satoh et al., 2007; Chin et al., 2008; Khan et al., 2010 | |
IL18 -137G"/C | rs187238 | Kim et al., 2008; Mittal et al., 2011 | donor:Mittal et al., 2011 |
IL18 –607A"/C | rs1946518 | Kolesar et al., 2007 | Mittal et al., 2011; donor: Mittal et al., 2011 |
IL23R +2199A"/C | rs10889677 | Tsai et al., 2011 |
3.3. Kidney transplantation is a challenging study subject
During the last decade, a number of genetic association studies focusing on the outcome in kidney transplantation have been published. The results as a whole are contradictory and the effect of genetic variation on the outcome of transplantation still requires confirmation. It might be that the results of genetic studies are not reproduced due to a high level of genetic and environmental heterogeneity, both certainly relevant in kidney transplantation. There is growing evidence that certain genes or gene loci, such as
As the current immunosuppressive regimens are very effective, the patients who still develop rejection, or some other complication, can be assumed to belong to the extreme high-responder end of patients. In genetic analysis this can be regarded as strength -we know we are studying the patients with a very strong tendency to develop immunological problems in kidney transplantation.
The problems related to the environmental factors can be reduced by a careful study design, such as attention to the precise definition of outcome phenotypes. Recruitment of sufficient numbers of patients would naturally improve the quality of studies. Prospective studies, if possible in a single centre single-centre would also be preferable, as many environmental factors could then be controllable but the number of cases available may remain relatively modest. Most studies have focused on allograft recipients, but evaluating also donors or even donor-recipient pairs, would give a new point of view.
Genetic variants should be carefully chosen instead of settling for a few most studied single nucleotide polymorphisms. Strong linkage disequilibrium (LD) influences association studies. It is currently assumed that our chromosomes are composed of haplotypic blocks that are relatively well conserved, in other words the genetic markers are said to be in linkage disequilibrium with each other. LD may help genetic studies as certain informative markers can be used as tags for a preliminary screening of haplotype blocks. On the other hand, the conserved structure of the blocks may be a hurdle in pinpointing the actual causative polymorphism. Exceptionally strong LD throughout the
More complex statistical analyses of many genetic and environmental variants simultaneously are required to test joint contributions to the risk and adjustment for potential confounders. Multivariate analyses have more power to detect minor impacts of single variables. Besides, correction of multiple comparisons is required due to a high probability of false positives (type 1 error) when several polymorphisms related to several outcomes are tested. A particular statistical challenge in the transplantation settings, which has not been tackled so far, is the fact that we are studying donor – recipient pairs instead of merely patients versus non-affected.
|
dbSNP rs number |
Citation Association |
Citation No association |
CD28-594A"/G | rs35593994 | Haimila et al., 2009b | |
CD28ivs3+17C"/T | rs3116496 | Krichen et al., 2010; Kusztal et al., 2010 | |
CTLA4-1722A"/G | rs733618 | Gendzekhadze et al., 2006 | |
CTLA4-1661G"/A | rs553808 | Gendzekhadze et al., 2006; Haimila et al., 2009b | |
CTLA4-1147C"/T | rs16840252 | Wisniewski et al., 2006;Kim et al., 2010 | |
CTLA4-318C"/T | rs5742909 | Wisniewski et al., 2006; Gorgi et al., 2006;Kusztal et al., 2007 | Dmitrienko et al., 2005; Gendzekhadze et al., 2006; Haimila et al., 2009b; Kim et al., 2010;Kusztal et al., 2010 |
CTLA4+49A"/G | rs231775 | Gendzekhadze et al., 2006; Gorgi et al., 2006; Kusztal et al., 2007; Kim et al., 2010; Kusztal et al., 2010 | Slavcheva et al., 2001; Dmitrienko et al., 2005; Wisniewski et al., 2006; Haimila et al., 2009b |
CTLA4(AT)n | Slavcheva et al., 2001; Kusztal et al., 2010 | Krichen et al., 2010 | |
CT60G"/A | rs3087243 | Haimila et al., 2009b | |
ICOSivs+173T"/C | rs10932029 | Haimila et al., 2009b | |
ICOSc602A"/C | rs10183087 | Haimila et al., 2009b | |
ICOSc1564C"/T | rs4404254 | Haimila et al., 2009b | |
ICOSc1624C"/T | rs10932037 | Haimila et al., 2009b | |
ICOSc2373G"/C | rs4675379 | Haimila et al., 2009b |
Although genome-wide association studies are simple to conduct and commonly used in other complex trait studies, none have been carried out in organ transplantation. In a typical genome-wide association study, up to a million genetic markers covering a significant portion of the common variation are simultaneously tested. The two main characteristics of genome wide studies are the large number of SNPs and the unbiased selection of these SNPs. Another approach, already demonstrated to be effective in bone marrow transplantation (McCarroll et al., 2009), is the systematic screening of gene deletions in the genome. Homozygous deletion of a gene in a recipient leads to immunological recognition of the encoded molecule if the graft can express the molecule. The results demonstrate that deletions are surprisingly common in our genome.
4. Conclusions
The identification of genetic factors that can modulate severity of acute rejection episodes may help to improve long-term graft survival. Functional variation in the gene regions of cytokines and/or T cell co-stimulatory receptors may affect the immune responsiveness of a graft recipient and thus, may predispose to the poor outcome of kidney transplantation. Technological advances in high-throughput genotyping methods would allow more intense genotyping of patients before transplantation. On the basis of genetic information, an amount of immunosuppressants could be set to a right level to avoid graft loss, on one hand, and undesired side effects of drugs, on the other hand.
The genes of cytokines and T cell co-stimulatory receptors are highly interesting but the final evidence for their role in renal transplantation still remains to be found. Genetic risk may not be due to a polymorphism in a single gene but rather a few haplotypes carrying a pattern of variations that act together. The combinatory effect may allow classification of patients into low- and high-responders. The involvement of several polymorphisms as well as confounding non-genetic factors, in particular differences in immunosuppression would explain the conflicting association reports from different populations. Larger studies are, however, still required. Even more importantly, true disease risk variants must be confirmed by functional assays. In addition, implementation of genome-wide association studies is necessary. Besides SNPs, the effect of structural variants, such as insertion/deletion and copy number variations should also be scrutinized in organ transplantation.
The major problem with genetic association studies is the small size of study populations (Hattersley & McCarthy, 2005). Although the sizes have increased in the more recent studies, the number of endpoint cases is still small and thus, the power of analysis is inadequate. The median rate of acute rejection was 18% in the recent multicentre study by Israni et al (2010). This means that thousands of patients need to be enrolled to the study before the number of acute rejection (or another endpoint) cases is sufficient for detecting the real underlying genetic variants, each of which may only have a weak individual effect.
Despite improved immunosuppressive medicaments, new organ preservation techniques, and decreased rejection rates, the improvement in long-term kidney allograft survival has been modest. There is growing interest in immunogenetics: if genetic factors determining the level of the immune response are combined with knowledge on effects of gene variation on drug metabolism, more personalized immunosuppression regimes for the patients can be developed.
References
- 1.
Abraham L. J. Kroeger K. M. 1999 Impact of the-308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease.66 0741-5400 562 566 - 2.
Alakulppi N. S. Kyllönen L. E. Jäntti V. T. Matinlauri I. H. Partanen J. Salmela K. T. Laine J. T. 2004 Cytokine gene polymorphisms and risks of acute rejection and delayed graft function after kidney transplantation.78 0041-1337 1422 1428 - 3.
Alakulppi N. S. Kyllonen L. E. Partanen J. Salmela K. T. Laine J. T. 2008 Lack of association between thrombosis-associated and cytokine candidate gene polymorphisms and acute rejection or vascular complications after kidney transplantation.23 1 364 368 0931-0509 - 4.
Amirzargar M. Yavangi M. Basiri A. Moghadam S. H. Khosravi F. Solgi G. Gholiaf M. Khoshkho F. Dadaras F. Mahmmodi M. Ansaripour B. Amirzargar A. Nikbin B. 2007 Genetic Association of Interleukin-4, Interleukin-10, and Transforming Growth Factor-beta Gene Polymorphism With Allograft Function in Renal Transplant Patients.39 0041-1345 954 957 - 5.
Aruffo A. Seed B. 1987 Molecular cloning of a CD28 cDNA by a high-efficiency COS cell expression system.84 23 8573 8577 0027-8424 - 6.
Asderakis A. Sankaran D. Dyer P. Johnson R. W. Pravica V. Sinnott P. J. Roberts I. Hutchinson I. V. 2001 Association of polymorphisms in the human interferon-gamma and interleukin-10 gene with acute and chronic kidney transplant outcome: the cytokine effect on transplantation.71 0041-1337 674 677 - 7.
Azarpira N. Aghdai M. H. Raisjalali G. A. Darai M. Tarahi M. J. 2009 Influence of recipient and donor IL-10, TNFA and INFG genotypes on the incidence of acute renal allograft rejection.36 6 1621 1626 1573-4978 - 8.
Azarpira N. Aghdaie M. Geramizadeh B. Behzadi S. Nikeghbalian S. Sagheb F. Rahsaz M. Behzad-Behbahanie A. Ayatollahi M. Darai M. Azarpira M. Banihashemie M. Tabei S. 2006 Cytokine gene polymorphisms in renal transplant recipients.4 1304-0855 528 531 - 9.
Beier K. C. Hutloff A. Dittrich A. M. Heuck C. Rauch A. Buchner K. Ludewig B. Ochs H. D. Mages H. W. Kroczek R. A. 2000 Induction, binding specificity and function of human ICOS.30 12 3707 3717 0014-2980 - 10.
Brabcova I. Petrasek J. Hribova P. Hyklova K. Bartosova K. Lacha J. Viklicky O. 2007 Genetic variability of major inflammatory mediators has no impact on the outcome of kidney transplantation.84 8 1037 1044 0041-1337 - 11.
Breulmann B. Bantis C. Siekierka M. Blume C. Aker S. Kuhr N. Grabensee B. Ivens K. 2007 Influence of cytokine genes polymorphisms on long-term outcome in renal transplantation.21 5 615 621 0902-0063 - 12.
Campistol J. M. Inigo P. Larios S. Bescos M. Oppenheimer F. 2001 Role of transforming growth factor-beta1 in the progression of chronic allograft nephropathy.16 Suppl 1,0931-0509 114 116 - 13.
Canossi, A.; Piazza, A.; Poggi, E.; Ozzella, G.; Di Rocco, M.; Papola, F.; Iaria, G. & Adorno, D. ( 2007 ). Renal Allograft Immune Response Is Influenced by Patient and Donor Cytokine Genotypes. Transplant Proc.,0041-1345 39 1805 1812 - 14.
Cartwright N. H. Keen L. J. Demaine A. G. Hurlock N. J. Mc Gonigle R. J. Rowe P. A. Shaw J. F. Szydlo R. M. Kaminski E. R. 2001 A study of cytokine gene polymorphisms and protein secretion in renal transplantation.8 0966-3274 237 244 - 15.
Cartwright N. H. Demaine A. G. Hurlock N. J. Mc Gonigle R. J. Rowe P. A. Shaw J. F. Szydlo R. M. Kaminski E. R. 2000 Cytokine secretion in mixed lymphocyte culture: a prognostic indicator of renal allograft rejection in addition to HLA mismatching.8 0966-3274 109 114 - 16.
Chin, G.K.; Adams, C.L.; Carey, B.S.; Shaw, S.; Tse, W.Y. & Kaminski, E.R. ( 2008 ). The value of serum neopterin, interferon-gamma levels and interleukin-12B polymorphisms in predicting acute renal allograft rejection. Clinical and experimental immunology,1365-2249 2 152 239 244 - 17.
Cho, J.H.; Huh, S.; Kwon, T.G.; Choi, J.Y.; Hur, I.K.; Lee, E.Y.; Park, S.H.; Kim, Y.L. & Kim, C.D. ( 2008 ). Association of C-509T and T869C polymorphisms of transforming growth factor-beta1 gene with chronic allograft nephropathy and graft survival in Korean renal transplant recipients. Transplantation proceedings,0041-1345 7 40 2355 2360 - 18.
Coppo R. Amore A. Chiesa M. Lombardo F. Cirina P. Andrulli S. Passerini P. Conti G. Peruzzi L. Giraudi R. Messina M. Segoloni G. Ponticelli C. 2007 Serological and genetic factors in early recurrence of IgA nephropathy after renal transplantation.21 6 728 737 0902-0063 - 19.
Crispim, J.C.; Wastowski, I.J.; Rassi, D.M.; Mendes-Junior Silva, C.T.; Bassi, C.; Castelli, E.C.; Costa, R.S.; Saber, L.T.; Silva, T.G. & Donadi, E.A. ( 2010 ). Interferon-gamma +874 polymorphism in the first intron of the human interferon-gamma gene and kidney allograft outcome. Transplantation proceedings,1873-2623 10 42 4505 4508 - 20.
Derynck R. Jarrett J. A. Chen E. Y. Eaton D. H. Bell J. R. Assoian R. K. Roberts A. B. Sporn M. B. Goeddel D. V. 1985 Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells.316 6030 701 705 0028-0836 - 21.
Dianzani S. Baron S. . 1996 Nonspecific Defenses. Library of Congress Cataloging-in-Publication Data, Texas - 22.
Dinarello C. A. 1997 Role of pro- and anti-inflammatory cytokines during inflammation: experimental and clinical findings.11 3 91 103 0039-3974 X - 23.
Ding, L.; Linsley, P.S.; Huang, L.Y.; Germain, R.N. & Shevach, E.M. ( 1993 ). IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. Journal of immunology (Baltimore, Md.: 1950),0022-1767 3 151 1224 1234 - 24.
Dmitrienko S. Hoar D. I. Balshaw R. Keown P. A. 2005 Immune response gene polymorphisms in renal transplant recipients.80 0041-1337 1773 1782 - 25.
Dong C. Juedes A. E. Temann U. A. Shresta S. Allison J. P. Ruddle N. H. Flavell R. A. 2001 ICOS co-stimulatory receptor is essential for T-cell activation and function.409 6816 97 101 0028-0836 - 26.
Duffy D. L. 2007 Genetic determinants of diabetes are similarly associated with other immune-mediated diseases.7 6 468 474 1528-4050 - 27.
Elahi M. M. Asotra K. Matata B. M. Mastana S. S. 2009 Tumor necrosis factor alpha-308 gene locus promoter polymorphism: an analysis of association with health and disease.1792 3 163 172 0006-3002 - 28.
Gendzekhadze K. Rivas-Vetencourt P. Montano R. F. 2006 Risk of adverse post-transplant events after kidney allograft transplantation as predicted by CTLA-4 +49 and TNF-alpha-308 single nucleotide polymorphisms: A preliminary study.16 0966-3274 194 199 - 29.
George S. Turner D. Reynard M. Navarrete C. Rizvi I. Fernando O. N. Powis S. H. Moorhead J. F. Varghese Z. 2001 Significance of cytokine gene polymorphism in renal transplantation.33 041-1345 483 484 - 30.
Gorgi, Y.; Sfar, I.; Abdallah, T.B.; Abderrahim, E.; Ayed, S.J.; Aouadi, H.; Bardi, R. & Ayed, K. ( 2006 ). Ctla-4 exon 1 (+49) and promoter (-318) gene polymorphisms in kidney transplantation. Transplantation proceedings,0041-1345 7 38 2303 2305 - 31.
Grenda R. Prokurat S. Ciechanowicz A. Piatosa B. Kalicinski P. 2009 Evaluation of the genetic background of standard-immunosuppressant-related toxicity in a cohort of 200 paediatric renal allograft recipients--a retrospective study.14 3 18 24 1425-9524 - 32.
Grinyo J. Vanrenterghem Y. Nashan B. Vincenti F. Ekberg H. Lindpaintner K. Rashford M. Nasmyth-Miller C. Voulgari A. Spleiss O. Truman M. Essioux L. 2008 Association of four DNA polymorphisms with acute rejection after kidney transplantation.21 9 879 891 0934-0874 - 33.
Hahn A. B. Kasten-Jolly J. C. Constantino D. M. Graffunder E. Singh T. P. Shen G. K. Conti D. J. 2001 TNF-alpha, IL-6, IFN-gamma, and IL-10 gene expression polymorphisms and the IL-4 receptor alpha-chain variant Q576R: effects on renal allograft outcome.72 0041-1337 660 665 - 34.
Haimila K. Einarsdottir E. Kauwe A. D. Koskinen L. L. Pan-Hammarström Q. Kaartinen T. Kurppa K. Ziberna F. Not T. Vatta S. Ventura A. Korponay-Szabo I. R. Adany R. Pocsai Z. Szeles G. Dukes E. Kaukinen K. Mäki M. Koskinen S. Partanen J. Hammarström L. Saavalainen P. 2009a The shared CTLA4-ICOS risk locus in celiac disease, IgA deficiency and common variable immunodeficiency.10 2 151 161 1476-5470 - 35.
Haimila K. Turpeinen H. Alakulppi N. S. Kyllönen L. E. Salmela K. T. Partanen J. 2009b Association of genetic variation in inducible costimulator gene with outcome of kidney transplantation.87 3 393 396 1534-6080 - 36.
Harper, K.; Balzano, C.; Rouvier, E.; Mattei, M.G.; Luciani, M.F. & Golstein, P. ( 1991 ). CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. Journal of immunology (Baltimore, Md.: 1950),0022-1767 3 147 1037 1044 - 37.
Hattersley A. T. Mc Carthy M. I. 2005 What makes a good genetic association study?366 1474-547 1315 1323 - 38.
Hehlgans T. Pfeffer K. 2005 The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games.115 0019-2805 1 20 - 39.
Hidalgo L. G. Halloran P. F. 2002 Role of IFN-gamma in allograft rejection.22 1040-8401 317 349 - 40.
Hoffmann S. Park J. Jacobson L. M. Muehrer R. J. Lorentzen D. Kleiner D. Becker Y. T. Hullett D. A. Mannon R. Kirk A. D. Becker B. N. 2004 Donor genomics influence graft events: the effect of donor polymorphisms on acute rejection and chronic allograft nephropathy.66 0085-2538 1686 1693 - 41.
Hoffmann T. W. Halimi J. M. Buchler M. Velge-Roussel F. Goudeau A. Al Najjar. A. Boulanger M. D. Houssaini T. S. Marliere J. F. Lebranchu Y. Baron C. 2008 Association between a polymorphism in the IL-12p40 gene and cytomegalovirus reactivation after kidney transplantation.85 10 1406 1411 0041-1337 - 42.
Holopainen, P.M. and Partanen, J.A. ( 2001 ). Technical note: linkage disequilibrium and disease-associated CTLA4 gene polymorphisms. Journal of immunology (Baltimore, Md. : 1950),0022-1767 167 2457 2458 - 43.
Hueso M. Navarro E. Moreso F. Beltran-Sastre V. Ventura F. Grinyo J. M. Seron D. 2006 Relationship Between Subclinical Rejection and Genotype, Renal Messenger RNA, and Plasma Protein Transforming Growth Factor-beta1 Levels.81 0041-1337 1463 1466 - 44.
Hutchings A. Guay-Woodford L. Thomas J. M. Young C. J. Purcell W. M. Pravica V. Perrey C. Hutchinson I. V. Benfield M. R. 2002 Association of cytokine single nucleotide polymorphisms with B7 costimulatory molecules in kidney allograft recipients.6 1397-3142 69 77 - 45.
Hutloff A. Dittrich A. M. Beier K. C. Eljaschewitsch B. Kraft R. Anagnostopoulos I. Kroczek R. A. 1999 ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28.397 6716 263 266 0028-0836 - 46.
Israni A. Leduc R. Holmes J. Jacobson P. A. Lamba V. Guan W. Schladt D. Chen J. Matas A. J. Oetting W. S. De Investigators K. A. F. 2010 Single-nucleotide polymorphisms, acute rejection, and severity of tubulitis in kidney transplantation, accounting for center-to-center variation.90 12 1401 1408 1534-6080 - 47.
Israni A. K. Li N. Cizman B. B. Snyder J. Abrams J. Joffe M. Rebbeck T. Feldman H. I. 2008 Association of donor inflammation- and apoptosis-related genotypes and delayed allograft function after kidney transplantation.52 2 331 339 1523-6838 - 48.
Jacobson P. A. Schladt D. Oetting W. S. Leduc R. Guan W. Matas A. J. Lamba V. Mannon R. B. Julian B. A. Israni A. for the. De investigators K. A. F. 2010 Genetic Determinants of Mycophenolate-Related Anemia and Leukopenia After Transplantation.1534-6080 1534 6080 - 49.
Jin Y. Ruiz P. 2008 Molecular genetic analysis of interleukin-1 promoter and receptor antagonist tandem repeat polymorphisms among HLA-identical renal transplant recipient and donor pairs.40 5 1329 1332 0041-1345 - 50.
Kaartinen T. Lappalainen J. Haimila K. Autero M. Partanen J. 2007 Genetic variation in ICOS regulates mRNA levels of ICOS and splicing isoforms of CTLA4.44 0161-5890 1655 1662 - 51.
Kao, C.C.; Lian, J.D.; Chou, M.C.; Chang, H.R. & Yang, S.F. ( 2010 ). Tumor necrosis factor alpha promoter polymorphism in posttransplantation diabetes mellitus of renal transplant recipients. Transplantation proceedings,1873-2623 9 42 3559 3561 - 52.
Khan F. Sar A. Gonul I. Benediktsson H. Doulla J. Yilmaz S. Berka N. 2010 Graft inflammation and histologic indicators of kidney chronic allograft failure: low-expressing interleukin-10 genotypes cannot be ignored.90 6 630 638 1534-6080 - 53.
Kim C. D. Ryu H. M. Choi J. Y. Choi H. J. Choi H. J. Cho J. H. Park S. H. Won D. I. Kim Y. L. 2008 Association of G-137C IL-18 promoter polymorphism with acute allograft rejection in renal transplant recipients.86 11 1610 1614 1534-6080 - 54.
Kim, H.J.; Jeong, K.H.; Lee, S.H.; Moon, J.Y.; Lee, T.W.; Kang, S.W.; Park, S.J.; Kim, Y.H. & Chung, J.H. ( 2010 ). Polymorphisms of the CTLA4 gene and kidney transplant rejection in Korean patients. Transplant immunology,1878-5492 1 24 40 44 - 55.
Kocierz M. Siekiera U. Kolonko A. Karkoszka H. Chudek J. Cierpka L. Wiecek A. 2011 G/C interleukin-6 gene polymorphism and the risk of transplanted kidney failure or graft loss during a 5-year follow-up period.77 4 283 290 1399-0039 - 56.
Kolesar L. Novota P. Krasna E. Slavcev A. Viklicky O. Honsova E. Striz I. 2007 Polymorphism of interleukin-18 promoter influences the onset of kidney graft function after transplantation.70 5 363 368 0001-2815 - 57.
Koss K. Satsangi J. Fanning G. C. Welsh K. I. Jewell D. P. 2000 Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies.1 3 185 190 1466-4879 - 58.
Kozak M. Kurzawski M. Wajda A. Lapczuk J. Lipski M. Dziewanowski K. Drozdzik M. 2011 TGF-beta1 gene polymorphism in renal transplant patients with and without gingival overgrowth.1601-0825 1601 0825 - 59.
Krajewska, M.; Koscielska-Kasprzak, K.; Weyde, W.; Drulis-Fajdasz, D.; Madziarska, K.; Mazanowska, O.; Kusztal, M. & Klinger, M. ( 2009 ). Impact of donor-dependent genetic factors on long-term renal graft function. Transplantation proceedings,1873-2623 8 41 2978 2980 - 60.
Krichen, H.; Sfar, I.; Hadj Kacem, H.; Bardi, R.; Jendoubi-Ayed, S.; Makhlouf, M.; Ben Romdhane, T.; Besseghair, F.; Aouadi, H.; Ben Abdallah, T.; Ayadi, H.; Ayed, K. & Gorgi, Y. ( 2010 ). (AT) repeat in the 3’ untranslated region of the CTLA-4 gene and susceptibility to acute allograft rejection in Tunisian renal transplantation. Transplantation proceedings,1873-2623 10 42 4314 4317 - 61.
Krichen, H.; Sfar, I.; Jendoubi-Ayed, S.; Makhlouf, M.; Ben Rhomdhane, T.; Bardi, R.; Aouadi, H.; Ben Abdallah, T.; Ayed, K. & Gorgi, Y. ( 2009 ). Genetic polymorphisms of immunoregulatory proteins in acute renal allograft rejection. Transplantation proceedings,1873-2623 8 41 3305 3307 - 62.
Kruger, B.; Walberer, A.; Farkas, S.; Tokmak, F.; Obed, A.; Schenker, P.; Henning, B.; Schlitt, H.J.; Kramer, B.K. & Banas, B. (2009). The impact of "high-producer" interleukin-6 haplotypes on cardiovascular morbidity and mortality in a kidney transplant population. Transplantation proceedings, 1873-2623 6 41 2539 2543 - 63.
Kusztal, M.; Koscielska-Kasprzak, K.; Drulis-Fajdasz, D.; Magott-Procelewska, M.; Patrzalek, D.; Janczak, D.; Chudoba, P. & Klinger, M. (2010). The influence of CTLA-4 gene polymorphism on long-term kidney allograft function in Caucasian recipients. Transplant immunology, 1878-5492 3 23 121 124 - 64.
Kusztal M. Radwan-Oczko M. Koscielska-Kasprzak K. Boratynska M. Patrzalek D. Klinger M. 2007 Possible association of CTLA-4 gene polymorphism with cyclosporine-induced gingival overgrowth in kidney transplant recipients.39 9 2763 2765 0041-1345 - 65.
La Manna G. Cappuccilli M. L. Cianciolo G. Conte D. Comai G. Carretta E. Scolari M. P. Stefoni S. 2010 Cardiovascular disease in kidney transplant recipients: the prognostic value of inflammatory cytokine genotypes.89 8 1001 1008 1534-6080 - 66.
Lacha J. Hribova P. Kotsch K. Brabcova I. Bartosova K. Volk H. D. Vitko S. 2005 Effect of cytokines and chemokines (TGF-beta, TNF-alpha, IL-6, IL-10, MCP-1, RANTES) gene polymorphisms in kidney recipients on posttransplantation outcome: influence of donor-recipient match.37 0041-1345 764 766 - 67.
Lee, D.Y.; Song, S.B.; Moon, J.Y.; Jeong, K.H.; Park, S.J.; Kim, H.J.; Kang, S.W.; Lee, S.H.; Kim, Y.H.; Chung, J.H.; Ihm, C.G. & Lee, T.W. ( 2010 ). Association between interleukin-3 gene polymorphism and acute rejection after kidney transplantation. Transplantation proceedings,1873-2623 10 42 4501 4504 - 68.
Lee H. Clark B. Gooi H. C. Stoves J. Newstead C. G. 2004 Influence of recipient and donor IL-1alpha, IL-4, and TNFalpha genotypes on the incidence of acute renal allograft rejection.57 0021-9746 101 103 - 69.
Ligeiro D. Sancho M. R. Papoila A. Barradinhas A. M. Almeida A. Calao S. Machado D. Nolasco F. Guerra J. Sampaio M. J. Trindade H. 2004 Impact of donor and recipient cytokine genotypes on renal allograft outcome.36 0041-1345 827 829 - 70.
Lin, M.T.; Storer, B.; Martin, P.J.; Tseng, L.H.; Gooley, T.; Chen, P.J. & Hansen, J.A. ( 2003 ). Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. The New England journal of medicine,1533-4406 23 349 2201 2210 - 71.
Ling V. Wu P. W. Finnerty H. F. Sharpe A. H. Gray G. S. Collins M. 1999 Complete sequence determination of the mouse and human CTLA4 gene loci: cross-species DNA sequence similarity beyond exon borders.60 3 341 355 0888-7543 - 72.
Lobashevsky, A.L.; Manwaring, J.E.; Travis, M.M.; Nord, B.L.; Higgins, N.G.; Serov, Y.A.; Arnoff, T.S.; Hommel-Berrey, G.A.; Goggins, W.C.; Taber, T.E.; Carter CB, S.; Smith, D.S.; Wozniak, T.C.; O’Donnell, J.A. & Turrentine, M.W. ( 2009 ). Effect of desensitization in solid organ transplant recipients depends on some cytokines genes polymorphism. Transplant immunology,1878-5492 3 21 169 178 - 73.
Loucaidou M. Stitchbury J. Lee J. Borrows R. Marshall S. E. Mc Lean A. G. Cairns T. Griffith M. Hakim N. Palmer A. Papalois V. Welsh K. Taube D. 2005 Cytokine polymorphisms do not influence acute rejection in renal transplantation under tacrolimus-based immunosuppression.37 0041-1345 1760 1761 - 74.
Low A. S. Azmy I. Sharaf N. Cannings C. Wilson A. G. 2002 Association between two tumour necrosis factor intronic polymorphisms and HLA alleles.29 1 31 34 0960-7420 - 75.
Manchanda P. K. Kumar A. Sharma R. K. Goel H. Mittal R. D. 2008 Association of pro/anti-inflammatory cytokine gene variants in renal transplant patients with allograft outcome and cyclosporine immunosuppressant levels.2 4 875 884 1177-5475 - 76.
Manchanda P. K. Mittal R. D. 2008 Analysis of cytokine gene polymorphisms in recipient’s matched with living donors on acute rejection after renal transplantation.311 1-2 57 65 0300-8177 - 77.
Marshall S. E. Mc Laren A. J. Mc Kinney E. F. Bird T. G. Haldar N. A. Bunce M. Morris P. J. Welsh K. I. 2001 Donor cytokine genotype influences the development of acute rejection after renal transplantation.71 0041-1337 469 476 - 78.
Marshall S. E. Mc Laren A. J. Haldar N. A. Bunce M. Morris P. J. Welsh K. I. 2000 The impact of recipient cytokine genotype on acute rejection after renal transplantation.70 0041-1337 1485 1491 - 79.
Martin J. Worthington J. Harris S. Martin S. 2009 The influence of class II transactivator and interleukin-6 polymorphisms on the production of antibodies to donor human leucocyte antigen mismatches in renal allograft recipients.36 4 235 239 0174-4313 X - 80.
Maury C. P. Teppo A. M. 1987 Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection.166 4 1132 1137 0022-1007 - 81.
Mc Adam A. J. Greenwald R. J. Levin M. A. Chernova T. Malenkovich N. Ling V. Freeman G. J. Sharpe A. H. 2001 ICOS is critical for CD40-mediated antibody class switching.409 6816 102 105 0028-0836 - 82.
Mc Carroll S. A. Bradner J. E. Turpeinen H. Volin L. Martin P. J. Chilewski S. D. Antin J. H. Lee S. J. Ruutu T. Storer B. Warren E. H. Zhang B. Zhao L. P. Ginsburg D. Soiffer R. J. Partanen J. Hansen J. A. Ritz J. Palotie A. Altshuler D. 2009 Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease.41 12 1341 1344 1546-1718 - 83.
Mc Daniel D. O. Barber W. H. Nguyan C. Rhodes S. W. May W. L. Mc Daniel L. S. Vig P. J. Jemeson L. L. Butkus D. E. 2003 Combined analysis of cytokine genotype polymorphism and the level of expression with allograft function in African-American renal transplant patients.11 0966-3274 107 119 - 84.
Meier-Kriesche H. U. Schold J. D. Srinivas T. R. Kaplan B. 2004 Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era.4 1600-6135 378 383 - 85.
Mendoza-Carrera F. Ojeda-Duran S. Angulo E. Rivas F. Macias-Lopez G. Buen E. P. Leal C. 2008 Influence of cytokine and intercellular adhesion molecule-1 gene polymorphisms on acute rejection in pediatric renal transplantation.12 7 755 761 1399-3046 - 86.
Mittal R. D. Srivastava P. Singh V. Jaiswal P. Kapoor R. 2011 Association of Common Variants of Vascular Endothelial Growth Factor and Interleukin-18 Genes with Allograft Survival in Renal Transplant Recipients of North India.1557-7430 1557 7430 - 87.
Muller-Steinhardt M. Fricke L. Muller B. Kirchner H. Hartel C. 2002 The interleukin-6-174promoter polymorphism is associated with long-term kidney allograft survival.63 0198-8859 S13 - 88.
Mytilineos J. Laux G. Opelz G. 2004 Relevance of IL10, TGFbeta1, TNFalpha, and IL4Ralpha Gene Polymorphisms in Kidney Transplantation: A Collaborative Transplant Study Report.4 1600-6135 1684 1690 - 89.
Nikolova P. N. Ivanova M. I. Mihailova S. M. Myhailova A. P. Baltadjieva D. N. Simeonov P. L. Paskalev E. K. Naumova E. J. 2008 Cytokine gene polymorphism in kidney transplantation- Impact of TGF-beta1, TNF-alpha and IL-6 on graft outcome.18 0966-3274 344 348 - 90.
Omrani M. D. Mokhtari M. R. Bagheri M. Ahmadpoor P. 2010 Association of interleukin-10, interferon-gamma, transforming growth factor-beta, and tumor necrosis factor-alpha gene polymorphisms with long-term kidney allograft survival.4 2 141 146 1735-8582 - 91.
Ozkaynak E. Gao W. Shemmeri N. Wang C. Gutierrez-Ramos J. C. Amaral J. Qin S. Rottman J. B. Coyle A. J. Hancock W. W. 2001 Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection.2 7 591 596 1529-2908 - 92.
Park J. Y. Park M. H. Park H. Ha J. Kim S. J. Ahn C. 2004 TNF-alpha and TGF-beta1 gene polymorphisms and renal allograft rejection in Koreans.64 0001-2815 660 666 - 93.
Pawlik A. Domanski L. Rozanski J. Czerny B. Juzyszyn Z. Dutkiewicz G. Myslak M. Halasa M. Slojewski M. Dabrowska-Zamojcin E. 2008 The association between cytokine gene polymorphisms and kidney allograft survival.13 1425-9524 54 58 - 94.
Pawlik, A.; Domanski, L.; Rozanski, J.; Florczak, M.; Dabrowska-Zamojcin, E.; Dutkiewicz, G. & Gawronska-Szklarz, B. (2005). IL-2 and TNF-alpha Promoter Polymorphisms in Patients With Acute Kidney Graft Rejection. Transplant.Proc, 0041-1345 37 2041 2043 - 95.
Pelletier R. Pravica V. Perrey C. Xia D. Ferguson R. M. Hutchinson I. Orosz C. 2000 Evidence for a genetic predisposition towards acute rejection after kidney and simultaneous kidney-pancreas transplantation.70 0041-1337 674 680 - 96.
Plothow A. Bicalho M. G. Benvenutti R. Contieri F. L. 2003 Interleukin-10 and acute rejection in renal transplantation.35 0041-1345 1338 1340 - 97.
Poli F. Boschiero L. Giannoni F. Tonini M. Scalamogna M. Ancona G. Sirchia G. 2000 Tumour necrosis factor-alpha gene polymorphism: implications in kidney transplantation.12 1043-4666 1778 1783 - 98.
Poole K. L. Gibbs P. J. Evans P. R. Sadek S. A. Howell W. M. 2001 Influence of patient and donor cytokine genotypes on renal allograft rejection: evidence from a single centre study.8 0966-3274 259 265 - 99.
Reviron D. Dussol B. Andre M. Brunet P. Mercier P. Berland Y. 2001 TNF-alpha and IL-6 gene polymorphism and rejection in kidney transplantation recipients.33 0041-1345 350 351 - 100.
Ro H. Hwang Y. H. Kim H. Jeong J. C. Lee H. Doh Y. S. Park H. C. Oh K. H. Park M. H. Ha J. Yang J. Ahn C. 2010 Association of Polymorphisms of Interleukin-8, CXCR1, CXCR2, and Selectin With Allograft Outcomes in Kidney Transplantation.1534-6080 1534 6080 - 101.
Rodrigo, E.; Sanchez-Velasco, P.; Ruiz, J.C.; Fernandez-Fresnedo, G.; Lopez-Hoyos, M.; Pinera, C.; Palomar, R.; Gomez-Alamillo, C.; Gonzalez-Cotorruelo, J.; Leyba-Cobian, F. & Arias, M. ( 2007 ). Cytokine polymorphisms and risk of infection after kidney transplantation. Transplantation proceedings,0041-1345 7 39 2219 2221 - 102.
Rubtsov Y. P. Rudensky A. Y. 2007 TGFbeta signalling in control of T-cell-mediated self-reactivity.7 1474-1733 443 453 - 103.
Sanchez-Velasco, P.; Rodrigo, E.; Fernandez-Fresnedo, G.; Ocejo-Vinyals, J.G.; Ruiz, J.C.; Arnau, A.; Leyva-Cobian, F. & Arias, M. ( 2010 ). Influence of interleukin-6 promoter polymorphism-174 g/c on kidney graft outcome. Transplantation proceedings,1873-2623 8 42 2854 2855 - 104.
Sankaran D. Asderakis A. Ashraf S. Roberts I. S. Short C. D. Dyer P. A. Sinnott P. J. Hutchinson I. V. 1999 Cytokine gene polymorphisms predict acute graft rejection following renal transplantation.56 0085-2538 281 288 - 105.
Satoh S. Saito M. Inoue K. Miura M. Komatsuda A. Habuchi T. 2007 Association of cytokine polymorphisms with subclinical progressive chronic allograft nephropathy in Japanese renal transplant recipients: preliminary study.14 11 990 994 0919-8172 - 106.
Singh, R.; Kesarwani, P.; Ahirwar, D.K.; Kapoor, R. & Mittal, R.D. ( 2009 ). Interleukin 8-251T>A and Interferon gamma +874A>T polymorphism: potential predictors of allograft outcome in renal transplant recipients from north India. Transplant immunology,1878-5492 1 21 13 17 - 107.
Slavcheva E. Albanis E. Jiao Q. Tran H. Bodian C. Knight R. Milford E. Schiano T. Tomer Y. Murphy B. 2001 Cytotoxic T-lymphocyte antigen 4 gene polymorphisms and susceptibility to acute allograft rejection.72 0041-1337 935 940 - 108.
Snanoudj R. de Preneuf H. Creput C. Arzouk N. Deroure B. Beaudreuil S. Durrbach A. Charpentier B. 2006 Costimulation blockade and its possible future use in clinical transplantation.19 9 693 704 0934-0874 - 109.
Swallow M. M. Wallin J. J. Sha W. C. 1999 B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFalpha.11 4 423 432 1074-7613 - 110.
Thakkinstian, A.; Dmitrienko, S.; Gerbase-Delima, M.; McDaniel, D.O.; Inigo, P.; Chow, K.M.; McEvoy, M.; Ingsathit, A.; Trevillian, P.; Barber, W.H. & Attia, J. ( 2008 ). Association between cytokine gene polymorphisms and outcomes in renal transplantation: a meta-analysis of individual patient data. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association- European Renal Association,1460-2385 9 23 3017 3023 - 111.
Thompson C. B. Lindsten T. Ledbetter J. A. Kunkel S. L. Young H. A. Emerson S. G. Leiden J. M. June C. H. 1989 CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines.86 4 1333 1337 0027-8424 - 112.
Tinckam K. Rush D. Hutchinson I. Dembinski I. Pravica V. Jeffery J. Nickerson P. 2005 The relative importance of cytokine gene polymorphisms in the development of early and late acute rejection and six-month renal allograft pathology.79 0041-1337 836 841 - 113.
Tivol E. A. Borriello F. Schweitzer A. N. Lynch W. P. Bluestone J. A. Sharpe A. H. 1995 Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4.3 5 541 547 1074-7613 - 114.
Tsai, J.P.; Yang, S.F.; Wu, S.W.; Hung, T.W.; Tsai, H.C.; Lian, J.D. & Chang, H.R. ( 2011 ). Association between interleukin 23 receptor polymorphism and kidney transplant outcomes: A 10-year Taiwan cohort study. Clinica chimica acta; international journal of clinical chemistry,1873-3492 - 115.
Turner M. S. Timms P. Hafner L. M. Giffard P. M. 1997 Identification and characterization of a basic cell surface-located protein from Lactobacillus fermentum BR11.179 10 3310 3316 0021-9193 - 116.
Uboldi de Capei. M. Dametto E. Fasano M. E. Messina M. Pratico’ L. Rendine S. Segoloni G. Curtoni E. S. 2004 Cytokines and chronic rejection: a study in kidney transplant long-term survivors.77 4 548 552 0041-1337 - 117.
Ueda H. Howson J. M. Esposito L. Heward J. Snook H. Chamberlain G. Rainbow D. B. Hunter K. M. Smith A. N. Di Genova G. Herr M. H. Dahlman I. Payne F. Smyth D. Lowe C. Twells R. C. Howlett S. Healy B. Nutland S. Rance H. E. Everett V. Smink L. J. Lam A. C. Cordell H. J. Walker N. M. Bordin C. Hulme J. Motzo C. Cucca F. Hess J. F. Metzker M. L. Rogers J. Gregory S. Allahabadia A. Nithiyananthan R. Tuomilehto-Wolf E. Tuomilehto J. Bingley P. Gillespie K. M. Undlien D. E. Ronningen K. S. Guja C. Ionescu-Tirgoviste C. Savage D. A. Maxwell A. P. Carson D. J. Patterson C. C. Franklyn J. A. Clayton D. G. Peterson L. B. Wicker L. S. Todd J. A. Gough S. C. 2003 Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease.423 6939 506 511 0028-0836 - 118.
Vincenti F. Luggen M. 2007 T cell costimulation: a rational target in the therapeutic armamentarium for autoimmune diseases and transplantation.58 347 358 0066-4219 - 119.
Vincenti, F. ( 2005 ). Current use and future trends in induction therapy. Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia,1319-2442 4 16 506 513 - 120.
Viola A. Lanzavecchia A. 1996 T cell activation determined by T cell receptor number and tunable thresholds.273 5271 104 106 0036-8075 - 121.
Waterhouse P. Penninger J. M. Timms E. Wakeham A. Shahinian A. Lee K. P. Thompson C. B. Griesser H. Mak T. W. 1995 Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4.270 5238 985 988 0036-8075 - 122.
Weimer, R.; Mytilineos, J.; Feustel, A.; Preiss, A.; Daniel, V.; Grimm, H.; Wiesel, M. & Opelz, G. ( 2003 ). Mycophenolate mofetil-based immunosuppression and cytokine genotypes: effects on monokine secretion and antigen presentation in long-term renal transplant recipients. Transplantation,0041-1337 75 2090 2099 - 123.
Wilson A. G. Symons J. A. Mc Dowell T. L. Mc Devitt H. O. Duff G. W. 1997 Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.94 0027-8424 3195 3199 - 124.
Wisniewski A. Kusztal M. Magott-Procelewska M. Klinger M. Jasek M. Luszczek W. Nowak I. Kosmaczewska A. Ciszak L. Frydecka I. Gorski A. Kusnierczyk P. 2006 Possible association of cytotoxic T-lymphocyte antigen 4 gene promoter single nucleotide polymorphism with acute rejection of allogeneic kidney transplant.38 1 56 58 0041-1345 - 125.
Wramner L. G. Norrby J. Hahn-Zoric M. Ahlmen J. Borjesson P. A. Carlstrom J. Hyt÷nen A. M. Olausson M. Hanson L. Padyukov L. 2004 Impaired Kidney Graft Survival is Associated with the TNF-alpha Genotype.78 0041-1337 117 121 - 126.
Yamada A. Salama A. D. Sayegh M. H. 2002 The role of novel T cell costimulatory pathways in autoimmunity and transplantation.13 2 559 575 1046-6673 - 127.
Yates P. J. Nicholson M. L. 2006 The aetiology and pathogenesis of chronic allograft nephropathy.16 3-4 148 157 0966-3274 - 128.
Yoshinaga S. K. Whoriskey J. S. Khare S. D. Sarmiento U. Guo J. Horan T. Shih G. Zhang M. Coccia M. A. Kohno T. Tafuri-Bladt A. Brankow D. Campbell P. Chang D. Chiu L. Dai T. Duncan G. Elliott G. S. Hui A. Mc Cabe S. M. Scully S. Shahinian A. Shaklee C. L. Van G. Mak T. W. Senaldi G. 1999 T-cell co-stimulation through B7RP-1 and ICOS.402 6763 827 832 0028-0836 - 129.
Zibar L. Wagner J. Pavlinic D. Galic J. Pasini J. Juras K. Barbic J. 2011 The relationship between interferon-gamma gene polymorphism and acute kidney allograft rejection.1365-3083 1365 3083